(Q51514899)

6 April 2018

title

Effect of ligustrazine on mice model of hepatic veno-occlusive disease induced by Gynura segetum. (English)

1 reference

6 April 2018

hepatic veno-occlusive disease

main subject

1 reference

Gynura segetum

1 reference

Zhe Chen

1

1 reference

6 April 2018

Ji-Rong Huo

series ordinal

2

1 reference

6 April 2018

Li Yang

series ordinal

3

1 reference

6 April 2018

Hong-Yi Zhu

series ordinal

4

1 reference

6 April 2018

publication date

1 June 2011

1 reference

6 April 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

6 April 2018

volume

26

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

1016-1021

1 reference

6 April 2018

The pathology, diagnosis, and treatment of hepatic veno-occlusive disease: current status and novel approaches

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Hepatic Veno-occlusive Disease (Sinusoidal Obstruction Syndrome) After Hematopoietic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Veno occlusive disease: update on clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Hepatoprotective and therapeutic effects of tetramethylpyrazine on acute econazole-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Effect of Ligustrazine on liver injury after burn trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Analysis, separation, and bioassay of pyrrolizidine alkaloids from comfrey (Symphytum officinale).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Development of a (32)P-postlabeling/HPLC method for detection of dehydroretronecine-derived DNA adducts in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Veno-occlusive disease: cytokines, genetics, and haemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Insights into defibrotide: an updated review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2011.06661.X

10.1111/J.1440-1746.2011.06661.X

21 January 2018

Identifiers

DOI

1 reference

6 April 2018

1 reference

6 April 2018